ASX - By Stock
|
LRK |
Re:
Valuation of Lark and stock-holdings
|
|
All4Info
|
59 |
38K |
3 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
59
|
38K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
3 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
29
|
11K
|
3
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
103 |
28K |
3 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
103
|
28K
|
3
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
103 |
28K |
2 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
103
|
28K
|
2
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
103 |
28K |
4 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
103
|
28K
|
4
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
103 |
28K |
7 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
103
|
28K
|
7
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Key Development in Current Paediatric ASD Study
|
|
All4Info
|
10 |
3.6K |
4 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
10
|
3.6K
|
4
|
|
ASX - By Stock
|
LRK |
Re:
Ann: March 2022 Quarterly Update and Appendix 4C
|
|
All4Info
|
15 |
8.9K |
1 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
15
|
8.9K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Ann: March 2022 Quarterly Update and Appendix 4C
|
|
All4Info
|
15 |
8.9K |
6 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
15
|
8.9K
|
6
|
|
ASX - By Stock
|
LRK |
Re:
$4.5m under the Modern Manufacturing Initiative…good news?
|
|
All4Info
|
11 |
5.3K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
11
|
5.3K
|
0
|
|
ASX - By Stock
|
LRK |
Re:
Ann: March 2022 Quarterly Update and Appendix 4C
|
|
All4Info
|
15 |
8.9K |
7 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
15
|
8.9K
|
7
|
|
ASX - By Stock
|
LRK |
Re:
Lark Distilling Co and the Bainbridge badger game
|
|
All4Info
|
2 |
1.1K |
0 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Q&A With Company CEO, Dr Alex Andrews
|
|
All4Info
|
7 |
2.7K |
2 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
7
|
2.7K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Q&A With Company CEO, Dr Alex Andrews
|
|
All4Info
|
7 |
2.7K |
4 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
7
|
2.7K
|
4
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
7 |
3.4K |
4 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
7
|
3.4K
|
4
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
7 |
3.4K |
1 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
7
|
3.4K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
7 |
3.4K |
2 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
7
|
3.4K
|
2
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Quarterly Activities Report & Appendix 4C
|
|
All4Info
|
25 |
11K |
9 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
25
|
11K
|
9
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
7 |
3.4K |
0 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
7
|
3.4K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Q&A With Company CEO, Dr Alex Andrews
|
|
All4Info
|
7 |
2.7K |
3 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
7
|
2.7K
|
3
|
|
ASX - By Stock
|
LRK |
Re:
Ann: Change in substantial holding
|
|
All4Info
|
7 |
3.4K |
2 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
7
|
3.4K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
4 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
29
|
11K
|
4
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
2 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
3 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
3 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
2 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
2 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Successful Landmark Study in Paediatric ASD
|
|
All4Info
|
29 |
11K |
6 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
29
|
11K
|
6
|
|
ASX - By Stock
|
LOM |
Re:
Ann: 11% Increase in Lulo Diamond Resource Carats
|
|
All4Info
|
8 |
4.8K |
11 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
8
|
4.8K
|
11
|
|
ASX - By Stock
|
LRK |
Re:
Valuation of Lark and stock-holdings
|
|
All4Info
|
59 |
38K |
6 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
59
|
38K
|
6
|
|
ASX - By Stock
|
LRK |
Re:
Valuation of Lark and stock-holdings
|
|
All4Info
|
59 |
38K |
1 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
59
|
38K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Valuation of Lark and stock-holdings
|
|
All4Info
|
59 |
38K |
3 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
59
|
38K
|
3
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
7 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
101
|
32K
|
7
|
|
ASX - By Stock
|
NTI |
Re:
Time to Buy ?
|
|
All4Info
|
40 |
12K |
1 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
40
|
12K
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Medicinal Cannabis Presentation
|
|
All4Info
|
6 |
2.1K |
2 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
6
|
2.1K
|
2
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
3 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
121
|
56K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Medicinal Cannabis Presentation
|
|
All4Info
|
6 |
2.1K |
4 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
6
|
2.1K
|
4
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
4 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
4
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
9 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
9
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
2
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
2
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
3
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
5 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
5
|
|
ASX - By Stock
|
LOM |
Re:
Ann: $12.5 Million Institutional Placement
|
|
All4Info
|
101 |
32K |
16 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
101
|
32K
|
16
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
121
|
56K
|
3
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
2 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
121
|
56K
|
2
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
2 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
121
|
56K
|
2
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
121
|
56K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
121
|
56K
|
1
|
|
ASX - By Stock
|
LRK |
Re:
Ann: CEO and Managing Director Change
|
|
All4Info
|
121 |
56K |
2 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
121
|
56K
|
2
|
|